Department of Hepatobiliary Surgery, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, China.
Department of Hepatobiliary Ultrasound, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, China.
Cancer Med. 2022 Mar;11(5):1357-1370. doi: 10.1002/cam4.4530. Epub 2022 Jan 6.
Liver cancer is one of the most common cancers worldwide. We aimed to report the burden of liver cancer at the global, regional, and national levels in 204 countries from 1990 to 2019, stratified by etiology, sex, age, and sociodemographic index (SDI).
Data of mortality, incidence, and disability-adjusted life years (DALYs) of liver cancer and its etiology were available from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2019. The trends in the liver cancer burden were assessed by the annual percentage change. All estimates are presented as numbers and age-standardized rates (ASRs) per 100,000 population, with uncertainty intervals (UIs).
Globally, 484,577 (95% UI 444,091-525,798) mortalities, 534,364 (486,550-588,639) incident cases, and 12,528,422 (11,400,671-13,687,675) disability-adjusted life years (DALYs) due to liver cancer occurred in 2019. The ASRs were 5.95 (5.44-6.44), 6.51 (5.95-7.16), and 151.08 (137.53-164.8) per 100,000 population for the mortalities, incidences, and DALYs, respectively. From 1990 to 2019, the numbers increased, whereas the ASRs decreased. Hepatitis B and Hepatitis C are the major causes of liver cancer mortality. The liver cancer mortality in 2019 increased with age, peaking at 65-69 and 70-74 age group in males and females, respectively, and the number was higher in males than in females. Generally, there were nonlinear associations between the ASR and SDIs values at the regional and national levels. China had the highest numbers of mortalities, incident cases, and DALYs, whereas Mongolia has the highest ASR in 2019.
Liver cancer remains a major public health issue worldwide, but etiological and geographical variations exist. It is necessary to increase awareness of the population regarding liver cancer, its etiologies and the importance of early detection, and diagnosis and treatment.
肝癌是全球最常见的癌症之一。本研究旨在报告全球 204 个国家和地区 1990 年至 2019 年按病因、性别、年龄和社会人口指数(SDI)分层的肝癌负担。
全球疾病、伤害和危险因素研究 2019 年提供了肝癌死亡率、发病率和伤残调整生命年(DALYs)及其病因的数据。采用年变化百分比评估肝癌负担变化趋势。所有估计值均以每 10 万人的数量和年龄标准化率(ASR)表示,置信区间(UI)。
2019 年,全球有 484577 例(95%UI 444091-525798)死亡、534364 例(486550-588639)新发病例和 12528422 例(11400671-13687675)因肝癌导致的伤残调整生命年(DALYs)。ASR 分别为每 10 万人 5.95(5.44-6.44)、6.51(5.95-7.16)和 151.08(137.53-164.8)。1990 年至 2019 年,数量增加,而 ASR 下降。乙型肝炎和丙型肝炎是肝癌死亡的主要原因。2019 年肝癌死亡率随年龄增长而上升,男性在 65-69 岁和 70-74 岁年龄组达到峰值,女性在男性高于女性。一般来说,在区域和国家层面,ASR 与 SDI 值之间存在非线性关系。中国的死亡人数、发病例数和 DALYs 最多,而蒙古 2019 年的 ASR 最高。
肝癌仍然是全球主要的公共卫生问题,但病因和地域存在差异。有必要提高人们对肝癌及其病因的认识,以及早期发现、诊断和治疗的重要性。